Atin Tomar
Founder / CEO
Yapan Bio
Yapan Bio specializes in process development, scale-up, and cGMP-compliant manufacturing of vaccines and biologics, utilizing advanced upstream and downstream techniques to ensure high product yield and stability. The company addresses the need for reliable and efficient production processes in the biopharmaceutical industry, facilitating human clinical studies through its integrated capabilities.
- Biotechnology
Updated 23 months ago
Funding
Raised to date
$170KRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Problem
The biopharmaceutical industry faces challenges in efficiently scaling up and manufacturing vaccines and biologics under cGMP guidelines, hindering the progress of human clinical studies due to inconsistent product yields and stability issues. Traditional manufacturing processes often lack the optimization needed for cost-effective and reliable production.
Solution
Yapan Bio offers process development, scale-up, and cGMP-compliant manufacturing services for vaccines and biologics, employing advanced upstream and downstream techniques to optimize product titer and stability. Their integrated capabilities facilitate human clinical studies by providing a reliable and efficient production process. They focus on process characterization, establishing small-scale models for unit operations and classifying process parameters to ensure consistent manufacturing output.
Target Audience
Yapan Bio serves biopharmaceutical companies requiring process development and cGMP manufacturing services for vaccines and biologics to support human clinical studies.
Features
- Process development and optimization for high product titer and stability.
- Upstream and downstream process development.
- Process characterization, including small-scale model establishment and qualification.
- Classification of process parameters and product quality attributes (critical, major, minor).
- cGMP manufacturing for human clinical studies.
- Cell and virus seed banking.
- Bioreactor capabilities including rocker, stirred tank, and adherent cell bioreactors.